Editorial Board
Masayoshi Yamaguchi
Department of Hematology and Medical Oncology, Emory University School of Medicine · United States
Editorial leadership for Journal of DNA And RNA Research ISSN 2575-7881
Research interests
- Dr. Yamaguchi Is Engaged In The Fields Of Endocrinology
- Cell Signaling Since 1971
- And These Researches Are Developed In The Aspect Of Biochemistry
- Molecular Biology
- Endocrinology
- Metabolism
- Nutrition
- Pharmacology
- And Toxicology. Dr. Yamaguchi Has An Interesting For Cell Signaling Mechanism
- Bone Biology
- Nutritional Factor
- Osteoporosis Prevention
- Diabetes
- Diabetic Osteoporosis
- Cell Signaling
- Cancer Biology
- And Cancer Bone Metastasis. He Also Discovered Two Novel Proteins
- Genes; Cell Signaling Suppressor Protein (Named Regucalcin; 1978) Transcriptional Factor Rgpr-P117 (Regucalcin Gene Promoter Region-Related Protein; 2001) In Mammalian Cells
Biography
- Dr. Masayoshi Yamaguchi is presently working as a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, USA.
- He also worked as Visiting Professor in the departments of Foods and Nutrition, Diabetes, Endocrinology, Metabolism, Pathobiology and also worked as Professor in the department of Nutritional Sciences.
- He had registered over 20 national and international patents in the fields of his research interesting.
Honor and awards:
- The Distinguished Service to Science Award from IBC (2007, England),
- Japan Society for Biomedical Research on Trace Elements Award 2007,
- International Biographical Dictionary (2006, IBC, England),
- Who’s Who in the World (2005, Marquis Who’s Who, USA),
- The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England),
- The World Lifetime Achievement Award from American Biographical Institute (2004, USA).
- He is serving as editors and editorial board members of reputed 60 international Journals.
Selected publications
- Regucalcin enhances adipocyte differentiation and attenuates inflammation in 3T3‐L1 cells 2020 cited 13×
- Metaxalone Suppresses Production of Inflammatory Cytokines Associated with Painful Conditions in Mouse Macrophages RAW264.7 Cells in Vitro: Synergistic Effect with β-caryophyllene 2020 cited 13×
- Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells 2021 cited 11×
- Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy 2023 cited 10×
- The Marine Factor 3,5-dihydroxy-4-methoxybenzyl Alcohol Suppresses Cell Growth, Inflammatory Cytokine Production, and NF-κB Signaling-enhanced Osteoclastogenesis in In vitro Mouse Macrophages RAW264.7 Cells 2024 cited 8×
- Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells 2022 cited 7×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JDRR for your work?
This journal is guided by Masayoshi Yamaguchi (Department of Hematology and Medical Oncology, Emory University School of Medicine) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.